Advanced Search

 

Study ID Status Title Patient Level Data
205767 Not yet recruiting A randomized, repeat dose, open label, parallel group, multi-center study to evaluate the effect of daprodustat compared to darbepoetin alfa on forearm blood flow in participants with anemia of chronic kidney disease that are not dialysis dependent
205779 Not yet recruiting Safety and protective effect study of GSK Biologicals’ Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in healthy female subjects from the HPV-039 study
205787 Completed Assessment of Patients Treated with Albiglutide - Phase 1
205791 Completed Meta-analysis to investigate effect of baseline eosinophils on lung function response to ICS Treatment (GW685698, GW642444M)
205794 Completed A Study to Evaluate the Efficacy of an Experimental Occlusion Technology Dentifrice in the Relief of Dentinal Hypersensitivity
205795 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444:2010(E))
205807 Recruiting Observational Study to describe the Prevalence of Severe Asthma in Spanish Hospitals
205808 Completed A double-blind, randomized, placebo controlled, dose escalating crossover study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in Japanese healthy male volunteers
205813 Not yet recruiting Methodology study to investigate the utility of retroviral insertion site analysis in samples from subjects treated with Strimvelis™ gene therapy
205815 Withdrawn Horlicks Cardia+: investigating the glycaemic index and satiety effect of Horlicks Cardia+
205816 Not yet recruiting Discrete Choice Experiment in Severe Asthma
205820 Completed A Two Part Study to Assess i) the Relative Bioavailability and Food Effect of a Novel Tablet Formulation of Boosted-GSK2838232 Compared to Capsule and ii) the Safety and Pharmacokinetics of Repeated Once-Daily Doses of Non-boosted GSK2838232
205821 Recruiting Study to elucidate the association of the Renin-angiotensin system and right ventricular function in mechanically ventilated patients
205822 Completed A double-blind (sponsor unblind), randomized, placebo-controlled, single and repeat escalating dose study to investigate the safety, tolerability, and pharmacokinetics of CCI15106 inhalation powder in healthy participants and participants with moderate chronic obstructive pulmonary disease (COPD) including evaluation of environmental and healthy by-stander exposure levels during dosing
205832 Completed A Phase IIb, 24 week, randomized, double-blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once-daily via a dry powder inhaler, versus placebo, in participants with asthma
205846 Not yet recruiting PRJ2693: Descriptive Analysis of Neuropsychiatric Diagnoses in Patients taking Dolutegravir in the OPERA® Observational Database
205847 Active, not recruiting Long term immunogenicity up to 15 years after the first booster immunization with GSK Biologicals’ Encepur Adults (Polygeline-free Tick-Borne Encephalitis vaccine for adults) in adults who received 1 of 3 different primary vaccination schedules
205854 Withdrawn A Phase IV, randomized, open-label study to evaluate one year long-term persistence of immune responses following two different rabies vaccine post-exposure regimens (Zagreb 2-1-1 and Essen 1-1-1-1-1) in Chinese Children
205862 Completed Claims-linked Survey Study to Assess Patient-reported COPD Symptoms and Burden of Illness among a Prevalent Population
205863 Not yet recruiting COPD Severity and Adherence to GOLD Guidelines in the Community Pharmacy Setting
205864 Recruiting A randomized, double-blind, Sponsor open, placebo-controlled, 52 week study evaluating the effect of danirixin (GSK1325756) on lung function and health related quality of life in participants with mild to moderate Chronic Obstructive Pulmonary Disease (COPD)
205865 Completed Sun Protection Factor Determination: In vivo Determination of the Sun Protection Factor (SPF): ISO 24444:2010(E)
205875 Not yet recruiting A Post-Marketing Observational Study to Evaluate the Safety of Tykerb® in Chinese Patients
205878 Completed PGX7647 (205878): Exploratory Pharmacogenetic GWAS meta-analysis of efficacy response to GSK1278863 by using subjects with CKD from phase 2 studies; 116581, 116582, 112844, 113633, 113747, and 116099
205881 Recruiting Evaluation of referring HCPs’ and parents’/carers’ understanding of specific risks associated with Strimvelis™ treatment

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.